Cargando…
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
Chemoresistance is a daunting challenge to the prognosis of patients with breast cancer. Signal transducer and activator of transcription (STAT) 5a plays vital roles in the development of various cancers, but its function in breast cancer is controversial, and its role in chemoresistance in breast c...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320598/ https://www.ncbi.nlm.nih.gov/pubmed/34336684 http://dx.doi.org/10.3389/fonc.2021.697950 |
_version_ | 1783730675405291520 |
---|---|
author | Li, Zhaoqing Chen, Cong Chen, Lini Hu, Dengdi Yang, Xiqian Zhuo, Wenying Chen, Yongxia Yang, Jingjing Zhou, Yulu Mao, Misha Zhang, Xun Xu, Ling Ju, Siwei Shen, Jun Wang, Qinchuan Dong, Minjun Xie, Shuduo Wei, Qun Jia, Yunlu Zhou, Jichun Wang, Linbo |
author_facet | Li, Zhaoqing Chen, Cong Chen, Lini Hu, Dengdi Yang, Xiqian Zhuo, Wenying Chen, Yongxia Yang, Jingjing Zhou, Yulu Mao, Misha Zhang, Xun Xu, Ling Ju, Siwei Shen, Jun Wang, Qinchuan Dong, Minjun Xie, Shuduo Wei, Qun Jia, Yunlu Zhou, Jichun Wang, Linbo |
author_sort | Li, Zhaoqing |
collection | PubMed |
description | Chemoresistance is a daunting challenge to the prognosis of patients with breast cancer. Signal transducer and activator of transcription (STAT) 5a plays vital roles in the development of various cancers, but its function in breast cancer is controversial, and its role in chemoresistance in breast cancer remains unexplored. Here we identified STAT5a as a chemoresistance inducer that regulates the expression of ABCB1 in breast cancer and can be targeted by pimozide, an FDA-approved psychotropic drug. First, we found that STAT5a and ABCB1 were expressed at higher levels in doxorubicin-resistant cell lines and chemoresistant patients, and their expression was positively correlated. Then, we confirmed the essential roles of STAT5a and ABCB1 in doxorubicin resistance in breast cancer cells and the regulation of ABCB1 transcription by STAT5a. Subsequently, the efficacy of pimozide in inhibiting STAT5a and sensitizing doxorubicin-resistant breast cancer cells was tested. Finally, we verified the role of STAT5a in doxorubicin resistance in breast cancer and the efficacy of pimozide in reversing this resistance in vivo. Our study demonstrated the vital role of STAT5a in doxorubicin resistance in breast cancer. Targeting STAT5a might be a promising strategy for treating doxorubicin-resistant breast cancer. Moreover, repurposing pimozide for doxorubicin resensitization is attractive due to the safety profile of pimozide. |
format | Online Article Text |
id | pubmed-8320598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83205982021-07-30 STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 Li, Zhaoqing Chen, Cong Chen, Lini Hu, Dengdi Yang, Xiqian Zhuo, Wenying Chen, Yongxia Yang, Jingjing Zhou, Yulu Mao, Misha Zhang, Xun Xu, Ling Ju, Siwei Shen, Jun Wang, Qinchuan Dong, Minjun Xie, Shuduo Wei, Qun Jia, Yunlu Zhou, Jichun Wang, Linbo Front Oncol Oncology Chemoresistance is a daunting challenge to the prognosis of patients with breast cancer. Signal transducer and activator of transcription (STAT) 5a plays vital roles in the development of various cancers, but its function in breast cancer is controversial, and its role in chemoresistance in breast cancer remains unexplored. Here we identified STAT5a as a chemoresistance inducer that regulates the expression of ABCB1 in breast cancer and can be targeted by pimozide, an FDA-approved psychotropic drug. First, we found that STAT5a and ABCB1 were expressed at higher levels in doxorubicin-resistant cell lines and chemoresistant patients, and their expression was positively correlated. Then, we confirmed the essential roles of STAT5a and ABCB1 in doxorubicin resistance in breast cancer cells and the regulation of ABCB1 transcription by STAT5a. Subsequently, the efficacy of pimozide in inhibiting STAT5a and sensitizing doxorubicin-resistant breast cancer cells was tested. Finally, we verified the role of STAT5a in doxorubicin resistance in breast cancer and the efficacy of pimozide in reversing this resistance in vivo. Our study demonstrated the vital role of STAT5a in doxorubicin resistance in breast cancer. Targeting STAT5a might be a promising strategy for treating doxorubicin-resistant breast cancer. Moreover, repurposing pimozide for doxorubicin resensitization is attractive due to the safety profile of pimozide. Frontiers Media S.A. 2021-07-15 /pmc/articles/PMC8320598/ /pubmed/34336684 http://dx.doi.org/10.3389/fonc.2021.697950 Text en Copyright © 2021 Li, Chen, Chen, Hu, Yang, Zhuo, Chen, Yang, Zhou, Mao, Zhang, Xu, Ju, Shen, Wang, Dong, Xie, Wei, Jia, Zhou and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Li, Zhaoqing Chen, Cong Chen, Lini Hu, Dengdi Yang, Xiqian Zhuo, Wenying Chen, Yongxia Yang, Jingjing Zhou, Yulu Mao, Misha Zhang, Xun Xu, Ling Ju, Siwei Shen, Jun Wang, Qinchuan Dong, Minjun Xie, Shuduo Wei, Qun Jia, Yunlu Zhou, Jichun Wang, Linbo STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
title | STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
title_full | STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
title_fullStr | STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
title_full_unstemmed | STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
title_short | STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
title_sort | stat5a confers doxorubicin resistance to breast cancer by regulating abcb1 |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320598/ https://www.ncbi.nlm.nih.gov/pubmed/34336684 http://dx.doi.org/10.3389/fonc.2021.697950 |
work_keys_str_mv | AT lizhaoqing stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT chencong stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT chenlini stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT hudengdi stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT yangxiqian stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT zhuowenying stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT chenyongxia stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT yangjingjing stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT zhouyulu stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT maomisha stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT zhangxun stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT xuling stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT jusiwei stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT shenjun stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT wangqinchuan stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT dongminjun stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT xieshuduo stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT weiqun stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT jiayunlu stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT zhoujichun stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT wanglinbo stat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 |